| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/25/2003 | CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response |
| 06/25/2003 | CN1426421A Tumour-specific animal proteins |
| 06/25/2003 | CN1426306A Method and compositions for impairing multiplication of HIV-1 |
| 06/25/2003 | CN1426304A Chemical Modification of mammalian urine and blood |
| 06/25/2003 | CN1426289A Method for expansion of epithelial stem cells |
| 06/25/2003 | CN1425448A Medicine for curing thrombotic phlebitis |
| 06/25/2003 | CN1425447A Traditional Chinese medicine composition for curing child's dyspepsia and cough and its preparing method |
| 06/25/2003 | CN1425445A Gubenhuiyuan traditional Chinese medicine composition and its method for producing oral liquid |
| 06/25/2003 | CN1425422A Medicine for curing diabetes and nephrosis and its preparing method |
| 06/25/2003 | CN1425416A Medicine for curing AIDS and its preparing method |
| 06/25/2003 | CN1425408A Pile internal treatment pill |
| 06/25/2003 | CN1425407A External treatment powder for piles |
| 06/25/2003 | CN1425399A Traditional Chinese medicine composition for curing rheumatism |
| 06/25/2003 | CN1425397A Sight promoting agent |
| 06/25/2003 | CN1425391A Thrombolytic leech capsule and its preparing method |
| 06/25/2003 | CN1425390A Composition for burn and scald |
| 06/25/2003 | CN1425389A Natural toad skin for curing AIDS |
| 06/25/2003 | CN1425388A Process for preparing enzymolysis pearl powder |
| 06/25/2003 | CN1425387A Hydrolytic extrating method for medicinal component of pilose antler |
| 06/25/2003 | CN1425386A Dimethyl-sulfone sulfide supplementary agent and its overlapped health articles |
| 06/25/2003 | CN1425329A Deer blood health articles |
| 06/25/2003 | CN1425318A Extracting method for poly element high quality biological protein of housefly |
| 06/25/2003 | CN1112336C Vital matter and preparing method thereof |
| 06/25/2003 | CN1112213C Medicine for treating skin disease and its preparing method |
| 06/25/2003 | CN1112212C Medicine liquid for treating pain of injury |
| 06/25/2003 | CN1112211C Medicine for treating lithiasis |
| 06/25/2003 | CN1112210C Chinese medicine preparation for invigorating kidney and activating blood circulation and its preparing process and application |
| 06/25/2003 | CN1112208C Chinese medicine for treating intraocular hemorrhage |
| 06/25/2003 | CN1112207C Oral Chinese medicine liquid for treating tumor |
| 06/25/2003 | CN1112206C Bone fracture setting medicine powder |
| 06/25/2003 | CN1112204C Traditional Chinese powder medicine for treating cough and preparation process thereof |
| 06/25/2003 | CN1112203C Chinese medicine for curing apoplexy |
| 06/25/2003 | CN1112202C Chinese herb medicine for treating coronary heart disease |
| 06/25/2003 | CN1112201C Chinese medicine for curing hepatitis B |
| 06/25/2003 | CN1112193C Chinese medicine for treating hepatitis B and hepatic fibrosis and its preparing process |
| 06/25/2003 | CN1112191C Medicine for treating rheumatic arthritis and hyperosteogeny and its preparing process |
| 06/25/2003 | CN1112189C Pearl water for health care |
| 06/25/2003 | CN1112175C Cosmetic or dermo-pharmaceutical products compatible with cutaneous ecology |
| 06/25/2003 | CN1112173C Specific cosmetic composition containing bear gall |
| 06/24/2003 | US6583276 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disorders |
| 06/24/2003 | US6583271 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 06/24/2003 | US6583121 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 06/24/2003 | US6582960 Generation of preferential chrondrocytes tissue; provide tissue, culture with fibroblast growth factor 2, propagate and harvest cells, generate tissue |
| 06/24/2003 | US6582947 Nucleotide sequences coding enzymatic polypeptide for use in the virus treatment of cancer and viral infection |
| 06/24/2003 | US6582709 Composition for topical application for the treatment of skin disorders and skin diseases, comprising 1-6 wt. % Dead Sea Mud as an active ingredient. Said composition is for use in treating skin disorders and skin diseases such as psoriasis, |
| 06/24/2003 | US6582705 Acellular antibordetella vaccine |
| 06/24/2003 | US6582697 Administering a synthetic conjugate comprising a carbohydrate antigenic determinant and an immunogenic carrier not naturally conjugated with said determinant; tumor prophylaxis and therapy for example |
| 06/24/2003 | US6582694 Method for preparing a viral aerosol |
| 06/24/2003 | US6582349 Blood processing system |
| 06/24/2003 | CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
| 06/19/2003 | WO2003050502A2 Prospective identification and characterization of breast cancer stem cells |
| 06/19/2003 | WO2003050272A2 Bone development model |
| 06/19/2003 | WO2003050271A2 In vitro production of dendritic cells from cd14+ monocytes |
| 06/19/2003 | WO2003050270A1 Method for producing stem cells with increased developmental potential |
| 06/19/2003 | WO2003050251A2 Hematopoietic cells from human embryonic stem cells |
| 06/19/2003 | WO2003050250A2 Chondrocyte precursors derived from human embryonic stem cells |
| 06/19/2003 | WO2003050249A2 Islet cells from human embryonic stem cells |
| 06/19/2003 | WO2003050241A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 06/19/2003 | WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity |
| 06/19/2003 | WO2003049797A1 Catheter for cell delivery in tissue |
| 06/19/2003 | WO2003049784A2 Manual processing systems and methods for providing blood components conditioned for pathogen inactivation |
| 06/19/2003 | WO2003049764A1 Composition for viral preservation |
| 06/19/2003 | WO2003049763A1 Composition for the preservation of viruses |
| 06/19/2003 | WO2003049752A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 06/19/2003 | WO2003049751A1 The process of manufacturing a pharmaceutical composition useful for management of cancer |
| 06/19/2003 | WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/19/2003 | WO2003049667A2 The method of treating cancer |
| 06/19/2003 | WO2003049552A2 Beverage treated with nicotine |
| 06/19/2003 | WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/19/2003 | US20030115623 Methods and compositions for producing donor cells, as well as tissues and organs comprising the same |
| 06/19/2003 | US20030114382 Angiogenesis inhibition |
| 06/19/2003 | US20030114381 Method of treating sensorineural hearing loss |
| 06/19/2003 | US20030113913 Culture product; gene therapy; amplification; induction cell differentiation |
| 06/19/2003 | US20030113900 Incubation, culture product, drying, stabilization; storage stability; freeze drying in presence of trehalose |
| 06/19/2003 | US20030113869 Human FGF gene and gene expression products |
| 06/19/2003 | US20030113840 25 human secreted proteins |
| 06/19/2003 | US20030113812 Evaluating modulators of neuron propagation; bone morphogenetic proteins; epidermal growth factors; erythropoietins; pleiotrophins; hepatocyte growth factors; somatomedins; nerve growth factors; interleukins |
| 06/19/2003 | US20030113809 In vitro model for gastrointestinal inflammation |
| 06/19/2003 | US20030113707 Erythrocyte transport protein suspension obtained by removing fibrin and separating erythrocytes from hematocrit; storage stability; antihypoxic agents |
| 06/19/2003 | US20030113418 Dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia. |
| 06/19/2003 | US20030113368 Holding capability for hydrophilic and lipophilic drugs, water-soluble and hydrophobic substaces; controlling sustained release |
| 06/19/2003 | US20030113355 Nontoxic vernix compositions and method of producing |
| 06/19/2003 | US20030113348 Non-laboratory strain used in the manufacture of a medicament for the oncolytic treatment of cancer; anticancer agents |
| 06/19/2003 | US20030113340 Methods of promoting tolerogenic immune responses and compositions therefor |
| 06/19/2003 | US20030113306 Probiotic lactobacillus casei strains |
| 06/19/2003 | US20030113305 Compositions and methods for treating diabetes |
| 06/19/2003 | US20030113303 Delivering a translocation stimulator to a target zone of the tissue, introducing human embryonic stem cells to the mammal for homing the human to the target zone of the tissue for effecting myogenesis at the target zone |
| 06/19/2003 | US20030113302 Use of recipient endothelial cells for enhanced vascularization of tissue and tissue-engineered construct transplants |
| 06/19/2003 | US20030113301 Muscle cells and their use in cardiac repair |
| 06/19/2003 | US20030113296 A tissue-specific transcriptional regulatory sequence(promoter or enhancer) operably linked to the coding region of a gene that is essential of replication of the vector (DNA tumor viral vector) |
| 06/19/2003 | US20030113295 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 06/19/2003 | US20030111084 Use of low-power laser irradiation for enhanced vascularization of tissue and tissue-engineered construct transplants |
| 06/19/2003 | US20030111020 Culture of sessile marine animals |
| 06/19/2003 | CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/19/2003 | CA2692325A1 Islet cells from human embryonic stem cells |
| 06/19/2003 | CA2470104A1 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 06/19/2003 | CA2469792A1 In vitro production of dendritic cells from cd14+ monocytes especially for the preparation of suspension, monolayer and three-dimensional cell and/or tissue models, and use of these models |
| 06/19/2003 | CA2469491A1 Composition for viral preservation |
| 06/19/2003 | CA2469483A1 Hematopoietic cells from human embryonic stem cells |
| 06/19/2003 | CA2469266A1 The method of treating cancer |